Skip to content
Clinical Trials – home
LatviaBack to Latvia

Clinical trials in Ogre

12 clinical trials in Ogre, Latvia. Every trial is listed in the EU Clinical Trials Register and updated daily.

LatviaOur site in LatviaKliniskiePetijumi.lv(opens in a new tab)
Ogre at a glance
12
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

12 trials in Ogre

Open in trial search
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Bi 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH

Atrial fibrillation

Not yet recruiting
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Regeneron Pharmaceuticals Inc.
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Dyslipidaemia

Not recruiting
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Evolocumab
  • Sponsor:Amgen Inc.

Arteriosclerosis

Not recruiting
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Institut De Recherches Internationales Servier IRIS
Investigational
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH

Hypercholesterolaemia

Not recruiting
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Inclisiran
  • Sponsor:Novartis Pharma AG
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Batoclimab
  • Sponsor:Immunovant Sciences GmbH

Atrial fibrillation+2

Not recruiting
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Bayer AG

Other cities in Latvia

The busiest research cities in the country

All 19 cities in Latvia

Clinical research in Ogre

What the registry says about research in the country

01 Cardiovascular Research

Innovative studies focusing on stroke prevention and cardiovascular health management, particularly examining new therapeutic approaches for patients with atrial fibrillation and investigating treatments for atherosclerotic cardiovascular disease.

  • Atrial Fibrillation Management
  • ASCVD Prevention
  • Stroke Risk Reduction

Advanced research comparing different anticoagulation strategies and preventive treatments for cardiovascular events.

02 Endocrine Disorders

Comprehensive research into Type 2 Diabetes management and its complications, including studies on combination therapies and the impact of treatments on diabetic retinopathy.

  • Diabetes Management
  • Glycemic Control
  • Diabetic Eye Disease

Evaluating innovative treatment combinations and their effects on long-term diabetes complications.

03 Metabolic & Eye Conditions

Cutting-edge research addressing Thyroid Eye Disease and cholesterol management, exploring new therapeutic options for patients with challenging metabolic conditions.

  • Hypercholesterolemia Treatment
  • TED Management
  • Lipid Control

Investigation of novel treatments aimed at improving patient outcomes and quality of life.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.